Friday, July 10, 2020
Home Life Style Health & Fitness Indigestion Drug Could Treat Mild COVID-19 Infection: Researchers

Indigestion Drug Could Treat Mild COVID-19 Infection: Researchers

A recent study shows that an Indigestion drug may help in the treatment of mild COVID-19 symptoms

A widely available and inexpensive drug that is used to ease the symptoms of indigestion may prove a worthy contender for treating COVID-19 infection in those whose disease doesn’t require admission to hospital, say researchers as per the Latest news on coronavirus disease (COVID-19).

According to the study, published in the journal Gut, the effects were felt within 24 to 48 hours of taking famotidine.

Famotidine (Pepcid AC) belongs to a class of drugs known as histamine-2 receptor antagonists, which reduce the amount of stomach acid produced.

Follow NewsGram on Instagram to stay updated about the World.

Famotidine can be taken in doses of 20-160 mg, up to four times a day, for the treatment of acid reflux and heartburn.

For the findings, the research team from Cold Spring Harbor Laboratory Cancer Centre in the US, picked 10 people (six men; four women) who developed COVID-19 infection, all of whom happened to have been taking famotidine during their illness.

Covid-19
The severity of symptoms like cough was measured during the study. Pixabay

The severity of five cardinal symptoms–cough; shortness of breath; fatigue; headache and loss of taste/smell as well as general unwellness–was measured using a version of a 4-point scale normally applied to assess the severity of cancer symptoms (ECOG PS).

All started taking famotidine when they were feeling very poorly with COVID-19, the symptoms of which had been going on from two up to 26 days at that point.

The most frequently used dose was 80 mg taken three times a day, with the average treatment period lasting 11 days, but ranging from five to 21 days.

The findings showed that all 10 patients said that symptoms quickly improved within 24-48 hours of starting famotidine and had mostly cleared up after 14 days.

Improvement was evident across all symptom categories assessed, but respiratory symptoms, such as cough and shortness of breath, improved more rapidly than systemic symptoms, such as fatigue, the study said.

Famotidine COVID-19
Some patients didn’t experience any side effects while on famotidine. Wikimedia Commons

Seven of the patients didn’t experience any side effects while on famotidine, and in the three who did, these were mild, and all but temporary forgetfulness were known side effects associated with taking the drug.

Also Read: Riders’ Safety Through Accountability In COVID World

While promising, the researchers point out that the findings might have been affected by ‘the placebo effect,’ and hazy recall, added to which the number of case study participants was small.

“Our case series suggests, but does not establish, a benefit from famotidine treatment in outpatients with COVID-19,” they cautioned.

“A rigorous clinical trial is now warranted to see if the drug could be an effective treatment for COVID-19,” they concluded. (IANS)

STAY CONNECTED

18,991FansLike
362FollowersFollow
1,782FollowersFollow

Most Popular

Less Sleep Can Harm Your Child’s Mental Health

Dear parents, if you want your child to be mentally fit, Read on. Inadequate nighttime sleep alters several aspects of children's emotional health, warn...

Add Fruits and Vegetables to Your Diet to Reduce Type 2 Diabetes Risk

Higher consumption of fruit, vegetables, and whole-grain foods are associated with a lower risk of developing type 2 diabetes, say researchers. The findings, published in...

In Conversation with Pravesh Mallick

Pravesh Mallick is an Indian and Nepali composer, songwriter and playback singer who has worked in several movies and projects including 'Transparency: Pardarshita', 'Jai...

Home-schooling Tips During Coronavirus

Parenting could be hard during a pandemic, especially when your child's physical classes are on hold. If you are helping your child learn from...

Dealing with Muscle Pain During Covid

In times of COVID-19 and the lockdown, most people have been staying indoors and levels of activity have decreased significantly. Work from home has...

49% Indians Feel Chinese Firms Should be Allowed to Sell Products: Survey

A survey has found that around 49 per cent of its respondents feel that Chinese companies should be allowed to sell products in India,...

People Opting for Domestic Trips Post-Pandemic

By Siddhi Jain After a long stretch of staying-at-home, consumers are quick to show willingness to go out and travel again, albeit within driving distance...

eRaksha Competition 2020: Creating Cyber Awareness Among Youth

Online learning has become the need of the hour and the most viable resource that has come to the aid of children and their...

Recent Comments